Allen D, Curran H V, Lader M
Department of Psychiatry, Institute of Psychiatry, Denmark Hill, London, UK.
Eur J Clin Pharmacol. 1991;40(4):355-62. doi: 10.1007/BF00265843.
The effects of a 10 day administration of clomipramine (25-50 mg t.i.d.), alprazolam (0.25-0.75 mg t.i.d.) and placebo were assessed in normal volunteers in a double-blind cross-over study. A battery of physiological, psychomotor and cognitive tests was administered both before and 3 h after drug on days 1, 5 and 10. The effects of alprazolam on EEG and evoked potentials were characteristic of benzodiazepines; clomipramine had little effect. In contrast, reaction speed was markedly slowed by clomipramine but little affected by alprazolam. Neither drug produced any accumulation of effect on a verbal recall task but neither did tolerance develop to the acute impairments produced by active treatments. Alprazolam produced an increase in levels of forgetting, especially on day 5. Subjective ratings for mood and bodily symptoms were adversely affected by clomipramine but little altered by alprazolam. It is suggested that some of the differences between drug treatments may be due to differences in the speed of onset of tolerance.
在一项双盲交叉研究中,对正常志愿者评估了为期10天服用氯米帕明(25 - 50毫克,每日三次)、阿普唑仑(0.25 - 0.75毫克,每日三次)和安慰剂的效果。在第1、5和10天,于给药前及给药后3小时进行了一系列生理、心理运动和认知测试。阿普唑仑对脑电图和诱发电位的影响具有苯二氮䓬类药物的特征;氯米帕明几乎没有影响。相比之下,氯米帕明显著减慢反应速度,而阿普唑仑对其影响很小。两种药物在言语回忆任务上均未产生任何效应累积,但对活性治疗产生的急性损伤也未产生耐受性。阿普唑仑导致遗忘水平增加,尤其是在第5天。氯米帕明对情绪和身体症状的主观评分有不利影响,而阿普唑仑对其影响很小。有人认为,药物治疗之间的一些差异可能归因于耐受性起效速度的不同。